PharmaShots | Incisive News in 3 Shots

Subscribe Now

IDH1-Mutated Cholangiocarcinoma

Thermo Fisher's Oncomine Dx Target Test Receives the US FDA's Approval as a CDx for the Treatment of IDH1-Mutated Cholangiocarcinoma

Thermo Fisher's Oncomine Dx Target Test Receives the US FDA's Approval as a CDx for the Treatment of IDH1-Mutated Cholangiocarcino...

August 26, 2021

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us